COVID-19 recommendations

Although we are learning to live with the residual impacts of the COVID-19 pandemic, healthcare services around the world continue to be differentially affected by variable infection pressures. As a result, guidance on continuing to treat patients safely in these challenging circumstances remains relevant.

The Vision Academy, in conjunction with the nAMD Barometer, has developed a variety of materials to support ophthalmologists in making appropriate treatment decisions in the COVID-19 era. These include two publications, two Letters to the Editor, a Viewpoint, an educational slide deck, a communication to healthcare professionals, customizable template letters to patients, and a range of infographics. All materials aim to provide detailed guidance according to different levels of epidemic pressure and many are available in multiple languages, downloadable from the Resource Zone section of our website.

Publication on use of anti-VEGF injections during COVID-19: responding to levels of epidemic pressure 

VIEW PUBLICATION

Publication on managing patients with retinal disease during the COVID-19 pandemic 

VIEW PUBLICATION

Letter to the Editor with an update on communicating with patients requiring anti-VEGF injections during COVID-19

VIEW LETTER TO THE EDITOR

Letter to the Editor on advice to patients with retinal disease and their families during the COVID-19 pandemic

VIEW LETTER TO THE EDITOR

Vision Academy's Viewpoint on the use of anti-VEGF intravitreal injections in the COVID-19 era

DOWNLOAD VIEWPOINT

Vision Academy's educational slide deck on the use of anti-VEGF intravitreal injections in the COVID-19 era

DOWNLOAD SLIDE KIT

Vision Academy's letter to HCPs on communicating with patients and their families

DOWNLOAD LETTER TO HCPs